Vertex Pharmaceuticals on Thursday won approval from the Food and Drug Administration for a non-opioid pain drug, clearing ...

The Naranjo nomogram was designed to evaluate single-drug adverse events, not drug drug interactions. Several of the questions on the Naranjo nomogram do not apply to potential drug drug ...

The long list of purported "vaccine side effects" was extracted from a report of adverse events, which are not the same as side effects. However, at least two conditions listed as adverse events ...

database to identify common and repeated patterns of preventable adverse drug events (ADEs) was analyzed. ADR reports collected from 1994 through 2000 were extracted from a teaching hospital's ADR ...

In order to improve communication between doctors and patients, researchers have now developed visual aids to help patients ...

(WHNT) — The Alabama Department of Public Health issued a statement Wednesday about its current investigation into certain “adverse events” following an injection. In the news release ...

It’s time to move on from treating heroin as Europe’s main drug problem, according to the head of the European Union’s drugs agency. That’s not to say heroin isn’t still a major problem.

Nearly half didn’t include information about the drugs’ adverse effects, warnings, and contraindications.

The Food and Drug Administration (FDA) said it approved Vertex Pharmaceuticals' Journavx for short-term pain after surgery or injuries, making it the first new pharmaceutical pain treatment in ...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. All day - WTI ...